JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M409772200 on October 8, 2004

J. Biol. Chem., Vol. 279, Issue 51, 53109-53115, December 17, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/51/53109    most recent
M409772200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fabbretti, E.
Right arrow Articles by Giniatullin, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fabbretti, E.
Right arrow Articles by Giniatullin, R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Identification of Negative Residues in the P2X3 ATP Receptor Ectodomain as Structural Determinants for Desensitization and the Ca2+-sensing Modulatory Sites*

Elsa Fabbretti{ddagger}, Elena Sokolova{ddagger}, Lara Masten, Marianna D'Arco, Alessandra Fabbro, Andrea Nistri§, and Rashid Giniatullin

From the Neurobiology Sector, International School for Advanced Studies (SISSA), Via Beirut 4, 34014 Trieste, Italy

On nociceptive neurons, one important mechanism to generate pain signals is the activation of P2X3 receptors, which are membrane proteins gated by extracellular ATP. In the presence of the agonist, P2X3 receptors rapidly desensitize and then recover slowly. One unique property of P2X3 receptors is the recovery acceleration by extracellular Ca2+ that can play the role of the gain-setter of receptor function only when P2X3 receptors are desensitized. To study negatively charged sites potentially responsible for this action of Ca2+, we mutated 15 non-conserved aspartate or glutamate residues in the P2X3 receptor ectodomain with alanine and expressed such mutated receptors in human embryonic kidney cells studied with patch clamping. Unlike most mutants, D266A (P2X3 receptor numbering) desensitized very slowly, indicating that this residue is important for generating desensitization. Recovery appeared structurally distinct from desensitization because E111A and D266A had a much faster recovery and D220A and D289A had a much slower one despite their standard desensitization. Furthermore, E161A, E187A, or E270A mutants showed lessened sensitivity to the action of extracellular Ca2+, suggesting that these determinants were important for the effect of this cation on desensitization recovery. This study is the first report identifying several negative residues in the P2X3 receptor ectodomain differentially contributing to the general process of receptor desensitization. At least one residue was important to enable the development of rapid desensitization, whereas others controlled recovery from it or the facilitating action of Ca2+. Thus, these findings outline diverse potential molecular targets to modulate P2X3 receptor function in relation to its functional state.


Received for publication, August 25, 2004 , and in revised form, October 5, 2004.

* This work is supported by Grant GGP04037 from Telethon Italy. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger} Both authors contributed equally to this work.

§ To whom correspondence should be addressed: SISSA, Via Beirut 4, 34014 Trieste, Italy. Tel.: 39-040-3787-228; Fax: 39-040-3787-528; E-mail: nistri{at}sissa.it.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
T. Pangrsic, M. Potokar, M. Stenovec, M. Kreft, E. Fabbretti, A. Nistri, E. Pryazhnikov, L. Khiroug, R. Giniatullin, and R. Zorec
Exocytotic Release of ATP from Cultured Astrocytes
J. Biol. Chem., September 28, 2007; 282(39): 28749 - 28758.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
E. Sokolova, A. Skorinkin, I. Moiseev, A. Agrachev, A. Nistri, and R. Giniatullin
Experimental and Modeling Studies of Desensitization of P2X3 Receptors
Mol. Pharmacol., July 1, 2006; 70(1): 373 - 382.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. J. Fountain and R. A. North
A C-terminal Lysine That Controls Human P2X4 Receptor Desensitization
J. Biol. Chem., June 2, 2006; 281(22): 15044 - 15049.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
E. B. Pratt, T. S. Brink, P. Bergson, M. M. Voigt, and S. P. Cook
Use-Dependent Inhibition of P2X3 Receptors by Nanomolar Agonist
J. Neurosci., August 10, 2005; 25(32): 7359 - 7365.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Z. Yan, Z. Liang, M. Tomic, T. Obsil, and S. S. Stojilkovic
Molecular Determinants of the Agonist Binding Domain of a P2X Receptor Channel
Mol. Pharmacol., April 1, 2005; 67(4): 1078 - 1088.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.